At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Letrozole Versus Danazole for Pain Management of Female Presenting With Endometriosis
In Brief
A Phase 2 clinical trial evaluating Letrozole and danazol for Endometriosis. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Background: Endometriosis is a chronic gynecological condition defined by the ectopic presence of endometrial glands and stroma outside the uterine cavity, most commonly diagnosed via laparoscopy. While its exact etiology remains uncertain, a positive family history is considered a significant risk factor. Danazol has historically demonstrated efficacy in alleviating endometriosis-related pain, while letrozole, primarily used in neoadjuvant settings, has recently emerged as a promising alternative. This study aimed to compare the mean reduction in pain scores between letrozole and danazol in women with laparoscopically confirmed endometriosis. Objective: To compare the efficacy of letrozole versus danazol in reducing pain scores among women diagnosed with endometriosis. Material \& Methods: Study Design: Randomized control trial Setting: Department of Obstetrics \& Gynaecology, Sharif Medical and Dental Hospital
Study Details
Timeline
Interventions
Letrozole 2.5 mg orally once daily for 12 weeks.
Danazol 200 mg orally twice daily for 12 weeks.